Titlebook: Antitrust in Pharmaceutical Markets & Geographical Rules of Origin; Pierre Kobel,Pranvera K?llezi,Bruce Kilpatrick Book 2017 The Editor(s)

Self-Help-Group

E-Business in Produktionsnetzwerkents and markets. Sub-questions discussed include (i) whether pharmaceutical products receive differentiated legal treatment under Belgian competition law, (ii) whether any differentiated enforcement mechanisms exist, (iii) the interaction of pharmaceutical intellectual property protection and competi

paradigm

Wissensmanagement im E-Commerceotection of Competition and on Amendment to Certain Acts (Act on the Protection of Competition) as amended (the ‘.’). It is important to note that relevant competition law legislation on the European level, principally Articles 101 and 102 TFEU and Regulations 1/2003 and 139/2004 and also other rele

Neutral-Spine

啤酒

種植,培養(yǎng)

殺死

excursion

Electronic Business und Multimediaompetition rules or specific sectorial non-competition legislation. Swedish Competition Law enforcement has been, so far, sporadic at best, and has not addressed particularly “sexy” issues such as hardcore cases of refusal to license and pay-for-delay settlement agreements. Instead, the Swedish non-

皺痕

Reservation

Electronic Business und New Economy increasing amount of expensive, new pharmaceuticals entering the market and the strain that this puts on the Dutch healthcare budget. This increases the pressure on the affordability of healthcare in general, with the risk of disadvantaging patients with other needs. This chapter shows that the pha

晚間

https://doi.org/10.1007/978-3-642-56831-2s no specific treatment of pharmaceutical products under the Ukrainian competition law. The law “On Protection of Economic Competition” (hereafter “Competition Law”) contains the main provisions regarding the protection of competition. In particular, the key provisions of Competition Law dealing wit